|
|
News Breaks | | | | December 21, 2012 | | 07:38 EDT |  | HZNP | Horizon Pharma to receive approval from UK MHRA
Horizon Pharma announced that the United Kingdom Medicines and Healthcare products Regulatory Agency, or MHRA, based on the favorable recommendation of their Commission on Human Medicines (CHM), will grant a Marketing Authorization for Duexis, pending review of updated licensing documents which the Company has provided to the MHRA. The MA of Duexis is for the treatment of osteoarthritis, or OA, rheumatoid arthritis, or RA, and ankylosing spondylitis, or AS, and to decrease the risk of developing upper gastrointestinal ulcers. Duexis is approved and available in the United States. | |
|
News For HZNP From The Last 14 Days Check below for free stories on HZNP the last two weeks. |
|
|
| May 10, 2013 | | 06:34 EDT |  | HZNP | Horizon Pharma reports Q1 adjusted EPS (30c), consensus (35c)
 Subscribe for More Information | | | May 6, 2013 | | 07:34 EDT |  | HZNP | Conference Forum to host a summit
Subscribe for More Information | |
|
|
|
|
|
|
